Close Menu

NEW YORK (GenomeWeb) – PerkinElmer announced today that it has reorganized its corporate structure in order to better position itself to grow in certain markets and better serve customers.

The company's diagnostics business will now be a standalone business segment, focused on reproductive health, diagnostics for emerging markets, and applied genomics, and will serve clinically oriented customers in regulated markets, PerkinElmer said. It will be led by Prahlad Singh, senior vice president and president of diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.